Capital International Investors Acquires 4,042 Shares of Humana Inc (NYSE:HUM)

Capital International Investors grew its holdings in shares of Humana Inc (NYSE:HUM) by 0.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 10,036,857 shares of the insurance provider’s stock after purchasing an additional 4,042 shares during the period. Humana makes up about 1.2% of Capital International Investors’ holdings, making the stock its 16th biggest holding. Capital International Investors owned 0.08% of Humana worth $3,678,710,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in HUM. Evoke Wealth LLC bought a new position in Humana during the third quarter worth $26,000. Penserra Capital Management LLC bought a new position in Humana during the third quarter worth $31,000. Lighthouse Financial Advisors Inc. bought a new position in Humana during the fourth quarter worth $31,000. Psagot Investment House Ltd. bought a new position in Humana during the third quarter worth $35,000. Finally, Tompkins Financial Corp bought a new position in Humana during the fourth quarter worth $55,000. 94.02% of the stock is owned by hedge funds and other institutional investors.

In other news, Director David A. Jr/Ky Jones sold 5,800 shares of Humana stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $256.19, for a total transaction of $1,485,902.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.42% of the stock is owned by company insiders.

A number of equities analysts recently weighed in on HUM shares. JPMorgan Chase & Co. lifted their target price on shares of Humana from $437.00 to $448.00 and gave the stock an “overweight” rating in a research note on Friday, January 3rd. Cantor Fitzgerald lifted their target price on shares of Humana from $345.00 to $400.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 5th. Wells Fargo & Co reissued an “overweight” rating and set a $400.00 target price (up previously from $338.00) on shares of Humana in a research note on Wednesday, December 11th. Barclays lifted their target price on shares of Humana from $327.00 to $358.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Goldman Sachs Group reissued a “buy” rating and set a $425.00 target price on shares of Humana in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and twelve have given a buy rating to the company’s stock. Humana currently has a consensus rating of “Buy” and an average target price of $384.00.

HUM traded up $14.48 during midday trading on Thursday, hitting $283.49. The company had a trading volume of 84,533 shares, compared to its average volume of 2,361,303. The company has a market capitalization of $30.92 billion, a price-to-earnings ratio of 14.06, a PEG ratio of 0.90 and a beta of 0.89. The stock’s 50 day moving average price is $331.10 and its 200 day moving average price is $322.94. Humana Inc has a 52 week low of $208.25 and a 52 week high of $384.99. The company has a quick ratio of 1.82, a current ratio of 1.82 and a debt-to-equity ratio of 0.41.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $2.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $0.08. The firm had revenue of $16.30 billion during the quarter, compared to analysts’ expectations of $16.15 billion. Humana had a net margin of 4.17% and a return on equity of 20.89%. The business’s revenue was up 15.0% on a year-over-year basis. During the same period last year, the company earned $2.65 earnings per share. Research analysts predict that Humana Inc will post 18.64 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.625 per share. This is a boost from Humana’s previous quarterly dividend of $0.55. This represents a $2.50 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date is Monday, March 30th. Humana’s dividend payout ratio (DPR) is currently 12.31%.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: What is the return on assets formula?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.